Prostate biopsy: past, present, and future.

M B T w T t d b p a p arcinoma of the prostate has long been of interest to urologists. Prostate cancer is among the leading cancers of men and still remains among the eading causes of cancer deaths.1 Great advances in the iagnosis of prostate cancer have evolved through the ast century, most notably, prostate-specific antigen PSA) measurement; however, its utility is as a screening ool, not as a diagnostic test. The reference standard for he diagnosis of prostate cancer remains tissue biopsy. aturally, the technique of prostate biopsy has also volved through the years with the advent of new techologies. This review outlines the past, present, and uture of prostate biopsy.

[1]  M. Terris,et al.  Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. , 1989, The Journal of urology.

[2]  D. L. Diamond,et al.  Analysis of prostate cancer by proteomics using tissue specimens. , 2005, The Journal of urology.

[3]  M. Remzi,et al.  The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. , 2005, The Journal of urology.

[4]  B. Djavan,et al.  Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy: preliminary report. , 2006, European urology.

[5]  J. Melamed,et al.  Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. , 1998, The Journal of urology.

[6]  Campbell Jh,et al.  Biopsy of Prostate , 1963 .

[7]  Amit Patel,et al.  Prostate cancer detection with office based saturation biopsy in a repeat biopsy population. , 2004, The Journal of urology.

[8]  F. Colby.  Carcinoma of the prostate: results of total prostatectomy. , 1953, The Journal of urology.

[9]  M. Noble,et al.  Correlation of ultrasound guided and digitally directed transrectal biopsies of palpable prostatic abnormalities. , 1991, The Journal of urology.

[10]  Daniel O Scharfstein,et al.  Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy. , 2005, Urology.

[11]  G. Gordon,et al.  A diagnostic test for prostate cancer from gene expression profiling data. , 2004, The Journal of urology.

[12]  C C Schulman,et al.  Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? , 2001, The Journal of urology.

[13]  F. Bianchi.  Practical advantages of the perineal biopsy of the prostate. , 1956, The Journal of urology.

[14]  J. Finelli,et al.  Biopsy of prostate. , 1960, The Journal of urology.

[15]  K. Shinohara,et al.  The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. , 2000, The Journal of urology.

[16]  R. S. Ferguson.  Prostatic neoplasms: Their diagnosis by needle puncture and aspiration , 1930 .

[17]  A. Zlotta,et al.  Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. , 2001, The Journal of urology.

[18]  O John Semmes,et al.  Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.